Digital Necrosis Induced by Erlotinib Treatment in Metastatic Adenocarcinoma of the Lung

Pierluigi Ballardini; Guido Margutti; Roberto Manfredini

doi:10.3747/co.v18i3.782

You are currently viewing a new version of our website. To view the old version click .

Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..

Article

1 June 2011

Digital Necrosis Induced by Erlotinib Treatment in Metastatic Adenocarcinoma of the Lung

and

Department of Internal Medicine Hospital of the Delta, Lagosanto, Italy

Author to whom correspondence should be addressed.

Curr. Oncol.2011, 18(3), 109-110;https://doi.org/10.3747/co.v18i3.782

Version Notes

Order Reprints

Abstract

Re: Husein–ElAhmed H, Callejas–Rubio JL, Del Olmo RO, Ríos–Fernandez R, Ortego–Centeno N. Severe Raynaud syndrome induced by adjuvant interferon alfa in metastatic melanoma. Curr Oncol 2010;17:122–3. [...]

Keywords:

Digital necrosis; erlotinib; lung cancer; systemic sclerosis

Article Metrics

Citations

Article Access Statistics

Journal Statistics

Multiple requests from the same IP address are counted as one view.

Uptake of Novel Medical Therapies in the General Population

Pan-Canadian Initiatives in Colorectal Cancer Screening: Adopting Knowledge Translation Tools to Accelerate Uptake and Impact